Company Short-Term Debts: ikenaoncology.com (IMA)

Public company logo of Ikena Oncology, Inc. (IMA)

ImageneBio Inc is striving for a breakthrough in personalized cancer immunotherapy, as evidenced by the company's short-term borrowings, where 0.00 becomes the new value of the indicator. Market capitalization relies on partnerships and licenses, while development is based on clinical trials of targeted therapies. However, limited cash and the probability of trial failures create serious financial threats.

Company Short-Term Loans and Borrowings: Ikena Oncology, Inc. (IMA) for 07/29/2025 - 10/28/2026

ImageneBio - analytical breakdowns and key metrics (IMA)

- price and consensus price forecast:
Price Chart Ikena Oncology, Inc.|IMA - Consensus Target
- market capitalization data:
Market Capitalization ImageneBio Inc|IMA - Enterprise Value
- book capitalization data:
Accounting Value per Share Ikena Oncology|IMA - Accounting Value of Company|Market Capitalization to Book Value Ratio ikenaoncology.com|IMA - Company Total Asset Base
- debt and liquidity data:
Debt to Equity ImageneBio Inc|IMA - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ikena Oncology, Inc.|IMA - Company Total Debt|Debt to Book Value ImageneBio Inc|IMA - Company Long-Term Debts|Company Short-Term Debt Ikena Oncology
Initial company analysis:ikenaoncology.com (IMA)
Flagship merchandise of Ikena Oncology, Inc.

Partner payments for the validation of oncomolecules generate the current cash flow of ImageneBio Inc. (IMA), supporting operational stability until the publication of clinical test results. By analyzing changes in short-term loan amounts, investors assess the total liabilities maturing within one year, which allows for the identification of liquidity shortage risks and the company's critical dependence on external debt capital compared to the sector.

Competitor analysis for ImageneBio Inc

ARGX: Company Short-Term Debt|BNTX - Company Current Liabilities|ABVX: Company Short-Term Debts|Company Short-Term Debts ADMA Corp|PTGX - Company Current Liabilities|Company Short-Term Loans and Borrowings immunovant.com|KNSA (Kiniksa) - Company Short-Term Debts|Short-Term Debt Volume GRFS (Grifols SA)|Adaptive Biotechnologies Corp - Company Short-Term Debt|Celldex Corp - Company Current Liabilities|AUPH: Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|VERA: Company Current Liabilities|DNTH (Dianthus Therapeutics Inc) - Company Short-Term Debts|Company Short-Term Debt Pharvaris Corp (PHVS)|Company Short-Term Indebtedness abcellera.com|Tourmaline Bio, Inc. - Company Short-Term Debts|Short-Term Debt precigen.com (PGEN)|Company Short-Term Debts PHAR|Nektar Therapeutics Inc - Short-Term Debt Volume|UPB: Company Short-Term Debt|ZBIO - Company Current Liabilities|IMNM: Company Short-Term Debts|gossamerbio.com (GOSS) - Company Short-Term Debts|KalVista Pharmaceuticals, Inc. - Company Short-Term Debts|Short-Term Indebtedness Septerna, Inc.|Pieris Pharmaceuticals Inc - Company Short-Term Debts|Short-Term Debt SVRA (Savara Pharma)|RIGL - Company Short-Term Debt|Company Short-Term Indebtedness anaptysbio.com ANAB|ATXS (Astria Therapeutics, Inc.) - Company Short-Term Debts|ENGN - Short-Term Debt|RAPT Therapeutics (RAPT) - Company Short-Term Debts|Aerovate Therapeutics (JBIO) - Company Short-Term Debt|ACRS: Company Short-Term Debts|Short-Term Debt Volume KYTX|Tiziana Life Sciences Ltd - Company Short-Term Debt|Short-Term Debt Cabaletta Bio Inc. CABA|Company Current Liabilities Ventyx Bio|Company Short-Term Loans and Borrowings Theratechnologies, Inc THTX|Company Short-Term Debts AVTX (Avalo Therapeutics, Inc)|ELDN: Short-Term Debt Volume|Company Short-Term Debt Agenus Inc.|Climb Bio Inc. (CLYM) - Company Short-Term Indebtedness|Company Short-Term Debts ZURA|Company Current Liabilities aTyr Pharmaceuticals|ADAG (Adagene) - Company Short-Term Debts|Short-Term Debt Volume STTK (shattucklabs.com)|Equillium - Company Short-Term Debt|Company Current Liabilities Connect Biopharma Holdings CNTB|Immunic Inc - Company Short-Term Debts|ATRA: Company Short-Term Debts|Company Short-Term Debt inflarx.de (IFRX)|x4pharma.com (XFOR) - Current Liabilities|ACET - Company Short-Term Debts|Company Short-Term Loans and Borrowings Celularity Corp|Company Short-Term Debts INMB|Company Short-Term Debts BRNS (Barinthus Biotherapeutics Corp)|Company Short-Term Debt Kezar Life Sciences|sabbiotherapeutics.com - Company Short-Term Loans and Borrowings|AKTX: Company Short-Term Debt|ENLV - Company Current Liabilities|QTTB: Company Short-Term Debts|Company Short-Term Debts GeoVax Corp|EDSA - Company Current Liabilities|Company Short-Term Loans and Borrowings ibioinc.com|CARM (Carisma Therapeutics) - Company Short-Term Debts|Short-Term Debt Volume XTLB (XTL Biopharmaceuticals Ltd)|Bolt Biotherapeutics, Inc. - Company Short-Term Debt|HCW Biologics, Inc. - Company Current Liabilities|APVO: Company Short-Term Debt|aimimmuno.com (AIM) - Company Current Liabilities|ADTX: Company Current Liabilities|GRI (GRI Bio Inc) - Company Short-Term Debts|Company Short-Term Debt XORTX (XRTX)|Company Short-Term Indebtedness Vyome Therapeutics|Revelation Biosciences - Company Short-Term Debts|Short-Term Debt indaptusrx.com (INDP)|Company Short-Term Debts SCNI|CalciMedica Inc - Short-Term Debt Volume|AFMD: Company Short-Term Debt|ALLK - Company Current Liabilities|HOOK: Company Short-Term Debts|IGM Biosciences (IGMS) - Company Short-Term Debts|iTeos Therapeutics, Inc. - Company Short-Term Debts|Short-Term Indebtedness Ocean Biomedical Inc|TC BioPharm (Holdings) PLC - Company Short-Term Debts|Short-Term Debt THRD (Third Harmonic Bio Inc)